| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 383.50M | — |
| Operating expense | — | — |
| Net income | 24.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PAHC returned +14.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -1.0% |
| 1 year | +14.6% |
| 5 years | +70.8% |
| 10 years | +86.1% |
| All-time high | $55.31 (Mar 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PAHC would be worth today ›Yes. Phibro Animal Health Corporation paid 4 dividends over the past 12 months. The most recent was $0.12 per share on Jun 3, 2026. The dividend yield is 1.32%.
Phibro Animal Health Corporation stock trades on NASDAQ under the ticker symbol PAHC.
Phibro Animal Health Corporation is part of the Healthcare sector.
Phibro Animal Health Corporation has a market cap of 1.49B USD, based on the latest quote.
Phibro Animal Health Corporation is scheduled to report earnings on Aug 26, 2026.
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
